PYRAZOLOPYRIMIDIN-VERBINDUNGEN

Patent europeic · EP2888264 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2888264
Numer da la dumonda
EP13756249
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
22-08-2013
Publitgà
01-07-2015
Concedì
27-09-2017
Stritgà
31-08-2018
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 487/04 (2006.01)
A61K 31/519 (2006.01)
A61P 37/00 (2006.01)
Prioritad
US 201261692853 P 24.08.2012
US 201361774094 P 07.03.2013
Dumonda PCT
PCT/US2013/056107 22.08.2013
Publicaziun PCT
WO2014/031815 27.02.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-03-2019

    Stritgà, taxa betg pajada

    Published in Swissreg on 20.03.2019

  2. 27-09-2017

    Concedì

    Published in Swissreg on 27.09.2017

Partidas

Possessur

GlaxoSmithKline LLC

251 Little Falls Drive, Wilmington, DE 19808, US

Inventur

COE, Diane, Mary

Stevenage Hertfordshire SG1 2NY, GB

SMITH, Stephen, Allan

Stevange Hertfordshire SG1 2NY, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.